BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/12/2021

FDA Classifies Transcutaneous Electrical Continence Device into Class II with Special Controls

The US Food and Drug Administration (FDA) is classifying the transcutaneous electrical continence device into Class II, requiring special controls to ensure its safety and effectiveness. This move aims to improve patients' access to innovative devices while maintaining regulatory oversight.

Source: Federal Register — Food and Drug AdministrationOpen original release →